Phase I Study of Selinexor, a Selective Inhibitor of Nuclear Export, in Combination With Fludarabine and Cytarabine, in Pediatric Relapsed or Refractory Acute Leukemia
Thomas Alexander(University of North Carolina at Chapel Hill), Jeffrey E. Rubnitz(St. Jude Children's Research Hospital), Ching‐Hon Pui(St. Jude Children's Research Hospital), Norman J. Lacayo(Lucile Packard Children's Hospital), John Choi(Children's of Alabama), Raul C. Ribeiro(St. Jude Children's Research Hospital)
Cited by 121
Related Papers
International Consensus Classification of Myeloid Neoplasms and Acute Leukemias: integrating morphologic, clinical, and genomic data
|Blood|2022|2.8k
Treatment of Acute Lymphoblastic Leukemia
|New England Journal of Medicine|2006|2k
Classification, subtype discovery, and prediction of outcome in pediatric acute lymphoblastic leukemia by gene expression profiling
|Cancer Cell|2002|1.9k
Acute lymphoblastic leukaemia
|The Lancet|2008|1.6k